Luo et al. Analysis on herbal medicines utilized for treatment of COVID-19, Acta Pharmaceutica Sinica B, 2020
It was a great honour to join the international research team (Beijing, Chengdu, Guangzhou, and Irland)(Luo et al. 2020). The findings were just published with Acta Pharmaceutica Sinica B, one of the top pharmaceutical journal.
As COVID-19 pandemic poses a substantial global public health threat, TCM (mostly herbal medicine) was used in 91.50% of the COVID-19 cases in China, showing encouraging results in improving symptom management and reducing the deterioration, mortality, and recurrence rates. We discovered that Glycyrrhizae Radix et Rhizome (Gan Cao), Scutellariae Radix (Huang Qin), and Armeniacae Semen Amarum (Xin Ren) were the most frequently utilized in clinics, most of which were antipyretic (47, 26.26%), expectorant and cough-suppressing (22, 12.29%), and dampness-resolving (21, 11.73%) from traditional descriptions. A total of 1212 chemical components containing β-sitosterol, stigmasterol, and quercetin were primarily selected.
The article aims to make more easily accessible and share historical herbal knowledge used in contemporary treatments in a modern manner to assist researchers to treat COVID-19.
Luo, Lu, Jingwen Jiang, Cheng Wang, Martin Fitzgerald, Weifeng Hu, Yumei Zhou, Hui Zhang, and Shilin Chen. 2020. “Analysis on Herbal Medicines Utilized for Treatment of COVID-19.” Acta Pharmaceutica Sinica B, May. https://doi.org/10.1016/j.apsb.2020.05.007.